ARCHIVES

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

This article is from The Cancer Letter archive.

Vol. 33 No. 07 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Letter To Pittsburgh Details Deficiencies In NSABP Operations

April 8, 1994

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

In Brief: NIDDK Begins BPH Trial; Roswell Park Honors Schwarzkopf; NRC Cites MIT

March 1, 1996

In Brief: NCAB ask Force Supports Group-Led Data and Safety Monitoring Committees

August 19, 1994

TJU Wins NCI Renewal Of Kimmel Center Core Grant; 11 NY Centers Testing Spiral CT.

July 13, 2001

Aggressive, Tailored Therapy Improves Survival, Study Finds

October 31, 2008